Laboratory services

Dear clients!
For your safety, EMC has established an enhanced disinfection mode.
COVID-19 test and testing for antibodies to COVID-19 at clinic and at home. COVID-19 absence certificate
Lung CT
Unique rehabilitation program for patients suffered from COVID-19.

Laboratory services

CodeServicePrice, euroPrice, roub
CLINICAL DIAGNOSTIC LABORATORY
BLOOD ANALYSIS
A000 Cell Blood Count+differential 47 4 372
A002 Cell Blood Count 27 2 512
A005 Sedimentation rate 16 1 488
A008 Reticulocytes 13 1 209
A009 Matching of blood and compatibility test 320 29 768
M125 Malaria test 67 6 233
URINE ANALYSIS
B500 Standard urine test 13 1 209
B502 Standard urine test with microscopy 24 2 233
B510 Urine pregnancy test (screening) 13 1 209
B511 Nechiporenko urine test 20 1 860
B512 Zimnitsky urine test 53 4 930
B513 3-portions urine test examination 40 3 721
B514 2-portions urine test examination 27 2 512
B515 Urine precipitate - Microscopy 13 1 209
B517 Creatinine Clearance 53 4 930
STOOL ANALYSIS
B306 Fecal examination for pancreatic elastase-1 55 5 116
M105 Coprology total 27 2 512
M110 Coprology (occult blood) 13 1 209
M111 Carbohydrates in faeces 40 3 721
M115 Enterobiasis 20 1 860
M120 Eggs of helminths (+protozoa) 27 2 512
M122 Protozoa in faeces 20 1 860
M390 Adenovirus and rotavirus (in stool) 28 2 605
M392 Cryptosporidium, Giardia, Entamoeba histolytica in stool 41 3 814
M391 Helicobacter pylori(in stool) 27 2 512
M393 Verotoxin in stool 50 4 651
M394 Norovirus in stool 25 2 326
M395 Calprotectin in stool (quantitative) 53 4 930
M396 Clostridium Difficile Toxin A & B 65 6 047
SPUTUM ANALYSIS
M150 Standard sputum test 27 2 512
M002 Nasal slime general clinical research 27 2 512
M355 M. Tuberculosis in sputum 33 3 070
SKIN& NAIL PLATES
M126 Microscopic examination of a scraping from the skin, papules and ulcers on the edges parasitos 20 1 860
M155 Examination of skin plate or nail plate for pathogenic fungi (one test) 47 4 372
M210 Demodex folliculorum 20 1 860
BIOCHEMICAL HAIR ANALYSIS
B208 Heavy metals and trace elements (23 elements) complex hair test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 150 13 954
TESTS OF THE UROGENITAL SYSTEMS
M220 Standard Vaginal Smear Test 20 1 860
M221 Standard Cervical Smear Test 20 1 860
M222 Standard Urethral Smear Test 20 1 860
M223 Standard prostatic fluid test 27 2 512
SEROUS CAVITIES& CYSTS FLUID TESTS
B620 Standard Synovial Fluid Test 27 2 512
B621 Standard Serous Fluid test 27 2 512
CEREBROSPINAL FLUID TESTS
B622 Standard cerebrospinal fluid test 33 3 070
B623 Glucose in cerebrospinal fluid 17 1 581
B624 Protein in cerebrospinal fluid 17 1 581
HEMOSTASIS SYSTEM
A020 APTT 16 1 488
A025 Prothrombin+INR 27 2 512
A027 Thrombin time 22 2 047
A030 Fibrinogen 16 1 488
A035 Antithrombin III 27 2 512
C139 Protein-C 47 4 372
C142 Protein-S 47 4 372
C515 D-DIMER 60 5 581
C305 Lupus anticoagulant (panel) 53 4 930
A033 Platelet aggregation 83 7 721
A031 FACTOR VON 170 15 814
A068 Fractions of hemoglobin (carboxyhemoglobin and methemoglobin) 30 2 791
A071 Investigation of the properties of a blood clot (thromboelastogram) 100 9 302
BLOOD DRUG RATES
B142 Folic acid 27 2 512
C710 Determination of ethanol in the blood 60 5 581
T010 Digoxin 79 7 349
T015 Determination of phenobarbital in blood 53 4 930
T020 Phenytoin 53 4 930
T025 Valproic Acid 53 4 930
T030 Carbamazepine 53 4 930
T080 Determination of tacrolimus in blood 59 5 488
T085 Levetiracetam (Keppra) 100 9 302
T097 Therapeutic drug monitoring of Topiramate 24 2 233
T098 Therapeutic drug monitoring of oxcarbazepine by its active metabolite (single sample analysis) 24 2 233
T100 Determination of the concentration of Amikacin in the blood 43 4 000
T101 The determination of the concentration of Gentamicin in the blood 43 4 000
T102 Determine the concentration of Vancomycin in the blood 43 4 000
T103 Therapeutic drug monitoring of methotrexate in the blood 40 3 721
NARCOTIC SCREENING
T075 Drug screening in urine 53 4 930
T086 Determination of the fraction transferin (CDT) (diagnosis of alcohol abuse) 39 3 628
T087 Hair analysis for determination of drug means, psychotropic or potent substances. (method GC – MS, HPLC) 187 17 395
T088 Amphetamines in urine (quantitative) 28 2 605
T089 Cocaine in urine (quantitative) 28 2 605
T090 Cannabinoids in urine (quantitative) 28 2 605
T091 Barbiturates in urine (quantitative) 25 2 326
T092 Benzodiazepines in urine (quantitative) 28 2 605
T095 Opiates in urine (quantitative) 28 2 605
T096 Urinalysis "bad habits" (nicotine, a psychotropic and narcotic substance, a psychoactive drug substances) 57 5 302
T099 Determination of nicotine and its metabolites in urine for differential diagnosis of active and passive smoking: nicotine, cotinine (GH-MS method) 29 2 698
BLOOD BIOCHEMISTRY
A060 Determination of the level of vitamin B12 (cyanocobalamin) in the blood 27 2 512
B002 Iron saturation of transferrin + Transferrin + Iron 39 3 628
B003 Ceruloplasmin 50 4 651
B004 Eosinophil Cationic Protein (ECP) 50 4 651
B007 Cuprum 22 2 047
B100 Glucose 13 1 209
B101 Standard glucose tolerance test 33 3 070
B102 Vitamin D 107 9 954
B103 Vitamin A 83 7 721
B104 Vitamin B1 83 7 721
B105 Cholesterol 13 1 209
B107 Pregnancy glucose tolerance test 33 3 070
B108 Vitamin B5 83 7 721
B109 Vitamin B6 83 7 721
B110 Cholesterol-HDL 20 1 860
B112 Vitamin C 83 7 721
B113 Vitamin E 83 7 721
B114 Vitamin K 83 7 721
B115 Cholesterol-LDL 20 1 860
B118 Lactate 25 2 326
B120 Triglycerides 13 1 209
B122 Angiotensin converting enzyme (ACE) 48 4 465
B125 Bilirubin total 13 1 209
B130 Bilirubin direct 13 1 209
B135 Albumin 13 1 209
B137 Homocysteine 67 6 233
B140 Creatinine 13 1 209
B144 Zink 38 3 535
B145 Iron 16 1 488
B148 Litium 74 6 884
B150 Iron binding capacity 20 1 860
B155 Total protein 13 1 209
B160 Protein fractionation (Electrophoresis) 27 2 512
B165 Lipoprotein A 27 2 512
B166 APO-A-1 protein 27 2 512
B167 APO-B protein 27 2 512
B170 Urea 13 1 209
B175 Uric acid 13 1 209
B180 Fructosamine 20 1 860
B188 Determination of bile acids in blood 45 4 186
B200 Calcium (total) 16 1 488
B202 Calcium (ionised) 20 1 860
B203 Heavy metals and trace elements (23 elements Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb) complex blood test 150 13 954
B205 Sodium/Potassium/Chloride 16 1 488
B207 Blood gases: рО2,рСО2,рН from venous blood + calculating parameters 27 2 512
B209 Blood gases: рО2,рСО2,рН from arterial blood + calculating parameters 27 2 512
B210 Magnesium 13 1 209
B215 Phosphate inorganic 13 1 209
B217 Complex blood analysis during dialysis: pH, glucose, electrolytes 136 12 651
B218 Complex blood analysis: gas and electrolyte compositions, glucose, lactate with calculated parameters in venous blood (for Maternity hospital) 47 4 372
B219 Study of dialysate for electrolyte composition, pH, glucose 131 12 186
B221 Complex blood analysis gas and electrolyte compositions, glucose, lactate in capillary blood (for Maternity hospital) 47 4 372
B300 Amylase 16 1 488
B305 Amylase pancreatic 16 1 488
B310 Lipase 16 1 488
B315 Lactatedehydrogenase (LDH) 13 1 209
B317 Erythropoietin 47 4 372
B320 Creatine Kinase 13 1 209
B325 Creatine Kinase MB 16 1 488
B330 Gamma Glutamyle Transferase (GGT) 13 1 209
B335 Acid phosphatase 16 1 488
B340 Alk. Phosphatase 13 1 209
B345 Alanine Amino Transferase (ALT) 13 1 209
B350 Aspartate Amino Transferase (AST) 13 1 209
B360 Cholinesterase 18 1 674
B362 Determination of C1 esterase inhibitor in blood 45 4 186
B400 C-Reactive Protein 20 1 860
B401 C-reactive protein high sensitivity 30 2 791
B405 Rheumatoid Factor 20 1 860
B410 Anti-streptolysin O titre 20 1 860
B411 Alfa-1-antitrypsin 27 2 512
C415 Ferritin 27 2 512
B430 Haemoglobin A1C 22 2 047
B435 Myoglobin 47 4 372
B440 Transferrin 27 2 512
B445 Troponin I 47 4 372
B450 Troponin T 47 4 372
B451 BNP (brain natriuretic peptide) 87 8 093
B452 Determination of a functional C1 esterase inhibitor 38 3 535
B556 The N-terminal peptide NT-proBNP 88 8 186
B604 Alpha-2-Macroglobuline 47 4 372
B610 Haptoglobin 47 4 372
B700 Tandem mass spectrometry (spectrum acylcarnitines, amino acids, organic acids 130 12 093
B702 Procalcitonin (quant) 60 5 581
URINE BIOCHEMISTRY
Urine Biochemistry- Random Portion
B021 Urolithiasis Early Diagnostics 47 4 372
B025 Microproteinuria 13 1 209
B132 Urea (random portion) 12 1 116
B133 Uric acid (random portion) 12 1 116
B139 The content of Cu (copper) in the urine (a single portion of urine) 14 1 302
B149 Determination of iodine content in urine - I (iodine) 12 1 116
B173 Glucose (random portion) 13 1 209
B182 Alpha Amylase (random portion) 18 1 674
B505 NA+/K+/Cl (random portion) 20 1 860
B204 Heavy metals and trace elements (23 elements) complex urine test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 150 13 954
B134 Calcium (random portion) 18 1 674
B008 The content of Cu (copper) in the urine (daily) 14 1 302
B703 Gas chromatography of urine (organic aciduria) 250 23 256
Biochemical Urine Analysis - 24h
B136 Albumin (24h) 18 1 674
B141 Creatinine (24h) 18 1 674
B171 Urea (24h) 18 1 674
B176 Uric acid (24h) 18 1 674
B177 Phosphate inorganic (24h) 18 1 674
B178 Magnesium (24) 18 1 674
B179 Glucose (24h) 18 1 674
B183 Total Protein (24h) 18 1 674
B506 Na (24h) 20 1 860
B507 K (24h) 20 1 860
B508 Cl (24h) 20 1 860
B516 Calcium urine test (24h) 22 2 047
B550 Oxalate in urine 40 3 721
B558 Determination of Beta-2-microglobulin (single dose of urine) 24 2 233
B562 Urine protein electrophoresis 40 3 721
B520 Stone chemistry - Profile 79 7 349
IMMUNOLOGY
Diagnostic Of The Body Immunological Status
B415 Immunoglobulin A (IgA) 19 1 767
B420 Immunoglobulin M (IgM) 19 1 767
B425 Immunoglobulin G (IgG) 19 1 767
C299 Circulating Immune Complex 22 2 047
C300 IgE total 27 2 512
C285 Interferon sensibility state 293 27 256
C288 Lymphocyte subpopulations/min.panel/(CD3,CD4,CD8,CD19,CD16(56)),CD3+HL 200 18 605
C289 Lymphocyte subpopulations (ext. panel) CD3,CD4,CD8,CD16(56),CD19,CD3+ HLA-DR+,CD3+CD16(56)+(EK-T),CD8+CD38+CD25+,CD3+CD56+,CD95,CD4/CD8 200 18 605
C293 Compliment Componenta C3 33 3 070
C294 Compliment Componenta C4 33 3 070
C295 Neutrophilic Bactericidal Activity (HCT test) 27 2 512
C290 Interleukin 6 34 3 163
C291 Interleukin 8 34 3 163
C296 Interleukin 10 34 3 163
C298 Tumor Necrosis Factor 39 3 628
C281 Interleukin 1 Beta 50 4 651
C307 Determination of amyloid - beta (1-42) in blood and in cerebrospinal fluid 83 7 721
B704 Oligoclonal IgG in liquorrhea & serum 120 11 163
Diagnosis Of Auto-Immune Diseases
C023 Cardiolipin antibodies, IgM 50 4 651
C029 Cytoplasmic antigen antibodies SS-A/Ro (anti-SS-A/Ro) 83 7 721
C101 Anti-smooth muscle antibodies (ASMA) 50 4 651
C102 Anti-mitochondrial antibodies (AMA) 50 4 651
C167 Determination of аntibodies to nuclear antigens (ANA), IgG, 25 antigens: nucleosomes, dsDNA, histones, Sm, RNP(68kD/A/C), Sm / RNP, SSA / Ro 60kD, SSA / Ro 52kD, SSB, Scl-70, Ku, PM-Scl 100, Mi-2, Jo-1, PL-7, PL-12, SRP, ribosomes, CENP-a / B, GP100, PC100, M2, M2/nPDC and f-actin; quality, with decoding 118 10 977
C168 Determination of аntibodies to liver antigens, IgG, 7 antigens: M2 / nPDC, gp210, sp100, LKM1, LC1, SLA, f-actin; with decoding 49 4 558
C169 Determination of аntibodies for diagnosis of polymyositis/ scleroderma, IgG, 8 antigens: Jo - 1, PL-7, PL-12, SRP, Mi-2, Ku, PM-Scl-100, Scl-70; quality,  with decoding 76 7 070
C171 Determination of аntibodies to extractable nuclear antigens (ENA screen) and nucleosomes, IgG, 7 antigens: nucleosomes, Sm, Sm/RNP, SSA (Ro), SSB (La), Jo-1, Scl-70; quality,  with decoding 22 2 047
C175 Determination of antibodies to myeloperoxidase (MPO), IgG; quantitative determination 18 1 674
C176 Determination of antibodies to proteinase 3 (PR3), IgG; highly sensitive method; quantitative determination 18 1 674
C183 Determination of antibodies against neuronal receptors and synaptic (NMDAR, LGl1, CASPR2, AMPA1R, AMPA2R, GABAb1R) in cerebrospinal fluid 220 20 465
C201 Saccharomyces cerevisiae antibodies (ASCA) 45 4 186
C203 Scl-70 antibodies 50 4 651
C225 Thyroglobulin antibody 33 3 070
C230 Thyroperoxidase antibody 33 3 070
C231 Auto AB TSH-receptor 53 4 930
C233 Antispermatic Antibodies 67 6 233
C235 AB Insulin IgG 40 3 721
C236 AB insular beta-cells 67 6 233
C240 Antibodies acetylcholine receptor 160 14 884
C241 Antibodies aquaporin 4( NMO) 84 7 814
C242 Antibodies skeletal muscles 70 6 512
C243 Antibodies gangliosides, blot 90 8 372
C244 Myositis antibodies, blot 90 8 372
C245 Anti-neuronal antibodies, blot 110 10 233
C246 Antibodies NMDA receptor 150 13 954
C247 Antibodies Sm 50 4 651
C248 Antibodies gliadine deamidated peptides IgG 45 4 186
C249 Antibodies gliadine deamidated peptides IgA 45 4 186
C250 Antibodies RNP-70 45 4 186
C252 Immunophenotypic diagnostics of Acute leukemia and evaluation of the minimal residual disease (IPT AL and MOB) 309 28 744
C253 Blood test on APG 111 10 326
C254 Evaluation of cellular immunity / Immunity / imony the status of standard (расшифровка в таблице) 55 5 116
C256 Definition of CD20 in peripheral blood 54 5 023
C257 Typing of CD-34 + cells 60 5 581
C258 Myelogram 131 12 186
C259 Study of blood serum for the presence of antibodies to muscle specific tyrosine kinase receptors by enzyme immunoassay 83 7 721
C260 Antibodies to myelin oligodendrocyte glycoprotein Anti-MOG 83 7 721
C261 Determination of Tau protein in biological fluids 83 7 721
C262 Determination of glial fibrillar acid protein (GFAP) 107 9 954
C263 Comprehensive study (immunophenotyping) panel for serous discharge: CD45/CD15/CD71/CD40/CD95/CD30/CD3/CD19 300 27 907
C317 Determining the concentration of the IgG4 subclass of immunoglobulins (diagnosis of autoimmune pancreatitis) 36 3 349
C500 Nuclear antibody (IF) 47 4 372
C505 Cardiolipin antibody IgG 47 4 372
C506 Cardiolipin antibody IgA 25 2 326
C521 Immunophenotypic diagnostics of lymphoproliferative diseases(IPT LLP)) 309 28 744
C533 Anti-dsDNA 53 4 930
C534 Anti-ssDNA 53 4 930
C535 Phospholipid Antibody IgG 53 4 930
C536 Phospholipid Antibody IgM 53 4 930
C830 Antibodies Prothrombin 40 3 721
C840 Antibodies Gliadin IgA 40 3 721
C841 Anti-Transglutaminase IgG 47 4 372
C842 Anti-Transglutaminase IgA 47 4 372
C845 Antibodies Reticulin 47 4 372
C846 Antibodies Endomysium 47 4 372
C847 Antibodies Platelet 53 4 930
C848 Antibodies Basic Skin Membrane 73 6 791
C849 Determination of antibodies to the basement membrane of the glomeruli of the kidneys, IgG 36 3 349
C850 Antibodies Gliadin IgG 40 3 721
C851 Beta2 – glycoprotein antibodies 50 4 651
C852 Annexin V antibodies 50 4 651
C853 ENA – extractive nuclear antibodies screen 61 5 674
C854 ANCA –Anti-Neutrophil cytoplasmatic antibodies 50 4 651
C855 Anti CCP – Anti-cyclic citrullinated peptide antibodies 50 4 651
Immune Hematological Analysis
A069 Determination of free light chains FLC in blood 55 5 116
A070 Determination of free light chains (FLC) in urine 35 3 256
ONCOLOGICAL TESTS
C405 PSA total 29 2 698
C410 PSA free 29 2 698
C420 AFP 29 2 698
C425 CEA 29 2 698
C430 CA 125 38 3 535
C435 CA 19-9 29 2 698
C440 CA 15-3 29 2 698
C442 CA 72 - 4 40 3 721
C443 Neuron-Specific Enolase (NSE) 60 5 581
C445 B2 microglobulin 33 3 070
C820 Cyfra-21-1 40 3 721
C822 Squamous Cell Carcinoma (SCC) 39 3 628
C821 UBC (Bladder Cancer Antigen) in urine 39 3 628
C823 HE4 40 3 721
C824 Chromogranin A 56 5 209
SEROLOGY
Syphilis Diagnosis
S000 Determination of anti-cardiolipin antibodies by microreaction precipitation (RPR) (Diagnosis of syphilis) 27 2 512
S001 Determination of antibodies to Treponema pallidum (total) 27 2 512
S010 Determination of antibodies to Treponema pallidum by indirect hemagglutination(TPHA) 33 3 070
S011 Detection of antibodies to Treponema pallidum by the RIBT method 40 3 721
S012 Detection of antibodies to Treponema pallidum by the RIF method 21 1 953
S091 Determination of anti-Treponema pallidum IgG immunoblot 103 9 581
S092 Determination of anti-Treponema pallidum IgM immunoblot 103 9 581
Isoserological Study
A050 ABo Blood group+rhesus factor 33 3 070
A055 Antierythrocytic antibodies (screening) 40 3 721
A056 Direct Cumbs test 33 3 070
A061 Detecting Kell antigen sistem 33 3 070
A064 Phenotyping Rh and Kell 35 3 256
DIAGNOSIS OF VIRAL INFECTIONS
C001 Anti-HIV 1, 2 + antigen p24 47 4 372
C001-SC Anti-HIV 1, 2 + antigen p24 state certificate 79 7 349
C004 Anti-HAV total 40 3 721
C006 Anti-HAV IgM 47 4 372
C007 Hepatitis D Virus HDV antibodies, total 28 2 605
C008 HBsAg 27 2 512
C010 HBeAg 47 4 372
C011 HDV antibodies, IgM 28 2 605
C012 Anti-HBc total 40 3 721
C013 HEV antibodies, IgG 28 2 605
C014 Anti-HBc IgM 47 4 372
C015 HEV antibodies, IgM 28 2 605
C016 Anti-Hbe 47 4 372
C018 Anti-HBs quant. 47 4 372
C020 Anti-HCV IgG 40 3 721
C021 Anti-HCV IgM 44 4 093
C026 Anti-CMV IgG 29 2 698
C028 Anti-CMV IgM 33 3 070
C030 Anti-Rubella IgG 29 2 698
C031 Anti-Parvovirus B19 IgG 40 3 721
C032 Anti Rubella IgM 33 3 070
C033 Anti-Parvovirus B19 IgM 40 3 721
C034 Anti Mumps IgG 53 4 930
C036 Anti Mumps IgM 53 4 930
C038 Anti Measles IgG 53 4 930
C040 Anti Measles IgM 53 4 930
C041 Human Herpes Virus 6 type antibodies (anti-HHV6) , IgG 47 4 372
C044 Anti-HSV 1 IgG 47 4 372
C046 Anti-HSV 1 IgM 53 4 930
C048 Anti-HSV 2 IgG 47 4 372
C050 Anti-HSV 2 IgM 53 4 930
C052 Anti-Varicella Zoster IgG 53 4 930
C054 Anti Varicella Zoster IgM 53 4 930
C058 Anti-EBV-VCA IgG 53 4 930
C060 Anti-EBV-VCA IgM 53 4 930
C094 IgG Respiratory syncytial virus 35 3 256
C096 IgM Respiratory syncytial virus 35 3 256
C152 IgG Dengue virus 25 2 326
C153 IgM Dengue virus 25 2 326
C154 Antibodies to Clostridium tetani (quantitative) 35 3 256
C155 Antibodies to nuclear antigen of Epstein-Barr lgG / EBV EBNA lgG 55 5 116
C156 Antibodies to early proteins of Epstein-Barr lgG / EBV EA IgG 55 5 116
C450 Adenovirus infection 67 6 233
C856 Anti- encephalitis IgG 55 5 116
C857 Anti- encephalitis IgM 55 5 116
S200 Cytomegalovirus (CMV) IgG Avidity 53 4 930
S210 Rubella IgG Avidity 38 3 535
DIAGNOSTICS OF BACTERIAL INFECTIONS
C062 Helicobacter pylori antibody quantitative 47 4 372
C064 Helicobacter pylori antibody blot 80 7 442
C072 Anti IgG Chlamydia trachomatis (IF/quant) 47 4 372
C081 Determination of antibodies to Bordetella pertussis IgA (quant.) 67 6 233
C082 Determination of antibodies to Bordetella pertussis IgG (quant.) 67 6 233
C083 Determination of antibodies to Bordetella pertussis IgM (quant.) 67 6 233
C099 M.Tuberculosis by the method of T-SPOT.TB. 130 12 093
C090 Borrelia burgdorf. IgG (qual) 67 6 233
C091 Borrelia burgdorf. IgM (qual) 67 6 233
C164 Serological diagnosis of borreliosis (immunochip) in blood and neurolynph 25 2 326
C165 Serological diagnosis of borreliosis (immunochip) in blood 14 1 302
C177 Determination of urease activity Helicobacter pylori, 13C (urease respiratory test) 36 3 349
C519 Anti IgG Legionella pneumophila (qual.) 89 8 279
C522 Anti IgM Legionella pneumophila (qual.) 89 8 279
C645 Brucella IgG 67 6 233
C647 Brucella IgM 67 6 233
D070 Chlamydia pneumoniae IgA 53 4 930
D071 Chlamydia pneumoniae IgG 53 4 930
D072 Anti IgM Chlamydia pneumoniae 53 4 930
D073 Chlamydia psittaci IgG (qual) 67 6 233
D074 Chlamydia psittaci IgM (qual) 67 6 233
D077 Chlamydia psittaci IgA (qual) 67 6 233
D079 Determination of IgG class antibodies to Mycoplasma hominis (quant.) 10 930
D110 Mycoplasma pneumoniae IgA (quant) 40 3 721
D115 Mycoplasma pneumoniae IgG (qual) 40 3 721
D120 Mycoplasma pneumoniae IgM (qual) 40 3 721
D124 IgG Yersinia enterocolitica and pseudotuberculosis 30 2 791
D125 IgA Yersinia enterocolitica and pseudotuberculosis 30 2 791
D322 AB Shigella flexneri (total) 60 5 581
D323 AB Shigella sonnei (total) 60 5 581
S070 Ureaplasma urealiticum IgA 67 6 233
S075 Ureaplasma urealiticum IgG 67 6 233
S231 Anti-Salmonella A,B,C1, C2, D, E 22 2 047
S232 Anti-Salmonella Typhi Vi-antigen 22 2 047
S233 Anti-Corinebacterium Diphtheriae 22 2 047
C053 Helicobacter pylori IgM 44 4 093
C063 Helicobacter pylori IgA 44 4 093
C103 Immunoblot Borrelia burgdorferi IgG 60 5 581
C104 Immunoblot Borrelia burgdorferi IgM 60 5 581
C123 Determination of IgA class antibodies to Chlamydia trachomatis (quant.) 10 930
C124 Determination of lgM class antibodies to Chlamydia trachomatis (quant.) 10 930
S007 Determination of antigen Legionella pneumophila in urine (express test) 25 2 326
S008 Determination of streptococcus pneumoniae antigen 25 2 326
HELMINTHIASIS DIAGNOSIS
D305 Determination of IgG class antibodies to Opisthorchis (qual.) 67 6 233
D306 Determination of IgG class аntibodies to Trichinella  (qual.) 67 6 233
D307 Determination of IgG class аntibodies to Toxocara (qual.) 67 6 233
D308 Determination of IgG class аntibodies to Echinococcus (qual.) 67 6 233
D311 Lamblia intestinalis IgG, IgM, IgA 47 4 372
D312 Lamblia intestinalis IgM 47 4 372
D315 Antibody to ascaris antigen IgG (qual.) 40 3 721
D324 Antibodies to Echinococcus gr. IgG (quantitatives) 67 6 233
D325 Antibodies to Opistorchis IgG (quantitatives) 67 6 233
D326 Antibodies to Toxocara IgG (quantitative) 67 6 233
D327 Antibodies to Trichinella lgG (quantitative) 67 6 233
D328 Antibodies Ascaris IgG (quantitative) 67 6 233
D329 The blood test for trichinosis (rostirolla) 19 1 767
D332 The blood test for anisakis (IgG) by ELISA 24 2 233
D333 Determination of antibodies class G (IgG) to the causative agent of leishmaniasis (IgG) in the blood by ELISA 35 3 256
C049 Strongyloides stercoralis antibodies 44 4 093
C051 Taenia solium antibodies, IgG 44 4 093
C055 Fasciola hepatica antibodies, IgG 44 4 093
C057 Schistosoma mansoni antibodies, IgG 44 4 093
DIAGNOSIS OF ANIMACULAR INFECTIONS
C022 Toxoplasma gondii IgG (quant) 29 2 698
C024 Toxoplasma gondii IgM (qual) 38 3 535
C075 Entamoeba histolytica antibodies, IgG (RPGA) 44 4 093
S220 Toxoplasma IgG Avidity 46 4 279
C625 Entamoeba sp AB (total) 80 7 442
HORMONE TESTS
Thyroid gland tests
C200 Thyroid stimulating hormone 27 2 512
C205 Total T3 27 2 512
C210 Free T3 27 2 512
C215 Total T4 27 2 512
C220 Free T4 27 2 512
C222 Calcitonin 40 3 721
C223 Thyroglobulin 40 3 721
C224 Thyroid Binding Globulin (TBG) 40 3 721
Reproduction
B151 Dihydrotestosterone 53 4 930
C100 Follicle stimulating hormone 29 2 698
C105 Luteinising hormone 29 2 698
C106 Globulin, linking sex hormones (SHBG) 47 4 372
C110 Testosterone 29 2 698
C115 Prolactin 29 2 698
C117 Testosterone Free 47 4 372
C125 Estradiol 29 2 698
C126 Estriol Free 38 3 535
C130 Progesterone 29 2 698
C141 Inhibin В 93 8 651
C143 AMH (Anti-Mullerian Hormone) 93 8 651
C159 Definition of Macroprolactin 10 930
C227 Androstenedione 60 5 581
C400 Beta HCG 33 3 070
C404 Androstanediol glucuronide 50 4 651
C407 Diagnostic risk of preeclampsia:PLGF; Soluble fms-like tyrosine kinase-1(sFlt-1); (sFlt-1)/ (PLGF) 80 7 442
IVF83 Evaluation of ovarian reserve 197.6 18 381
Follicle stimulating hormone
Fertility specialist consultation including ultrasound examination
AMH (Anti-Mullerian Hormone)
FUNCTIONAL STATE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
B525 Ketosteroids-17 (urine) 38 3 535
B531 17-alpha-Hydroxy-Progesteron 29 2 698
B536 Free cortisol (urine, 24h) 40 3 721
C120 Cortisol 29 2 698
C135 Dehydroepiandrosterone 33 3 070
C140 Adrenocorticotrophin 53 4 930
C178 Comprehensive blood test for unsaturated fatty acids of the Omega-3 family: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), alpha-linolenic acid (ALA), gas chromatography - mass spectrometry (GC-MS) method 41 3 814
C179 Determination of the Omega-3 index (assessment of the risk of sudden cardiac death, myocardial infarction and other cardiovascular diseases), gas chromatography - mass spectrometry (GC-MS) method) 46 4 279
C180 A comprehensive blood test for unsaturated fatty acids of the Omega-6 family: linoleic, gamma-linolenic, digamogamma-linolenic, arachidonic, eicosadienic, docosadienic, docosatetraenoic acids, gas chromatography - mass spectrometry (GC-MS) method 41 3 814
C181 Comprehensive blood test for unsaturated fatty acids of the Omega-3 and Omega-6 family, gas chromatography - mass spectrometry (GC-MS) method 82 7 628
C452 Determination of cortisol in saliva 25 2 326
C453 Complex testing (stress, hormones): determination of cortisol and dehydroepiandrosterone in saliva 62 5 767
C454 The definition of a set of hormones: androgens, glucocorticoids, mineralocorticoids, progestogen them precursors and metabolites (12 indicators) 117 10 884
C462 The definition of a set of hormones: androgens, glucocorticoids, mineralocorticoids, estrogens, progestogen, their precursors and metabolites (16 indicators): 17-Oh-pregnenolone, testosterone, dehydroepiandrosterone, dehydroepiandrosterone-sulfate, аndrostenedione, cortisol, cortisone, 11-deoxycortisol, 21-deoxycortisol, deoxycorticosterone, corticosterone, estradiol, estron, estriol, progesterone, 17-hydroxyprogesterone in the blood 114 10 605
DIAGNOSTICS OF CONGENITAL & HEREDITARY DISEASES
G005 Triple test (trisomia-21; with conclusion) 1 trimester 127 11 814
G007 Triple test (trisomia-21; with conclusion) 2 trimester 127 11 814
G123 Mucoviscidosis CFTR 300 27 907
G423 A study of the fragmentation of sperm DNA by the method of SCD 283 26 326
G500 Study of sperm fertility using method TUNEL 260 24 186
METABOLISM OF BONE TISSUE
C131 Osteocalcin 46 4 279
C132 Parathormone 47 4 372
C144 Beta – CrossLaps (product of degradation of I type collagen) 44 4 093
C147 Bone resorption - deoxypiridinolin 67 6 233
C182 Study of the level of N-terminal propeptide of type 1 procollagen (P1NP) in the blood 18 1 674
METABOLIC NATRIUM & WATER CONTROL OF HORMONE SYSTEMS
B521 Renin, Aldosterone 80 7 442
SOMATOTROPH FUNCTIONS OF THE PITUITARY GLAND
B526 Human growth hormone 46 4 279
B527 Somatomedin-C 46 4 279
INCRETORY FUNCTION OF PANCREATIC
B532 Insulin 40 3 721
B533 Proinsulin 60 5 581
B534 С-peptide 47 4 372
B539 Antibody-GAD 53 4 930
C108 Leptin 53 4 930
C146 Gastro panel (pepsinogen I, pepsines Helicobacter pyloriogen II, gastrin 17 (basal), IgG antibodi) 75 6 977
C158 Melatonin 51 4 744
INCRETORY FUNCTION OF THE GASTROINTESTINAL TRACT
B535 Gastrin 53 4 930
BIOGENIC AMINES
C700 Serotonin 60 5 581
C800 Histamine 60 5 581
C900 Tryptase 75 6 977
FUNCTIONAL STATW OF SYMPATHIC-ADRENAL SYSTEM
C157 Catecholamines and serotonin 38 3 535
C118 Determination of catecholamines in daily urine (noradrenaline, adrenaline, dopamine) 60 5 581
C172 Determination of metabolites of biogenic amines: homovanilic acid (GVK), vanillin-mandelic acid (IUD) in urine, 24 h. 22 2 047
C173 Definition of free fractions of a metanefrin and normetanefrin (nekonyyugirovanny with SO4) in urine, 24 h. 24 2 233
C174 Determination of total epinephrine and norepinephrine metabolites: metanephrine, normetanephrine (free and conjugated with SO4) in urine, 24 h. 24 2 233
ALLERGOLOGY
Specific Ige
C310 Allergy tests/each test 20 1 860
C311 Specific IgE for Allergen Mix / qual 33 3 070
C312 Single recombinant allergic components, inhalation (One name) 20 1 860
C313 Single recombinant allergic components, nutritional (group 1) (One name) 11 1 023
C314 Single recombinant allergic components, nutritional 2 (group 2) (One name) 20 1 860
C315 General Inhalation Allergy Panel 160 14 884
C331 ImmunoCap allergocomponent diagnostics, IgG determination for monitoring ASIT therapy: t215 birch wart/betula verrucosa, recombinant allergocomponent (rBet vl/PR-10 protein) 43 4 000
C332 ImmunoCap allergocomponent diagnostics, IgG determination for monitoring ASIT therapy: g213 timothy meadow/phleum pratense, recombinant allergocomponent(rPhl pl, rPhl p5) 43 4 000
C333 ImmunoCap allergocomponent diagnostics, IgG determination for monitoring ASIT therapy: w230 ambrosia elatior, a. artemisiifolia, ative allergosorbent(nAmb al) 43 4 000
C334 ImmunoCap allergocomponent diagnostics, IgG determination for monitoring ASIT therapy: w231 artemisia vulgaris,native allergosorbent(nArt vl) 43 4 000
C340 General Food Panel 160 14 884
C350 Allergy Panel/ primary screening 120 11 163
C351 Allergy pediatric panel, IgE (20 allergens) 156 14 512
C358 Children's Panel - Screening (Phadiatop Infant ImmunoCAP): Determination of specific IgE to the common allergens responsible for the development of allergies in children (without decoding). Recommended for children up to 3 years. 28 2 605
C359 Inhalation panel - Screening (Phadiatop ImmunoCAP): determination of specific IgE to inhalant allergens (without decoding) 22 2 047
C362 Antibacterial drugs (antibiotics) (specific IgE), one name. 10 930
C363 Analgesics and non-steroidal anti-inflammatory drugs (specific IgE). One name. 10 930
C364 Local anesthetics (specific IgE). One name. 10 930
C365 Antibacterial drugs (antibiotics) (specific IgG). One name. 21 1 953
C366 Analgesics and non-steroidal anti-inflammatory drugs (specific IgG). One name. 20 1 860
C367 Local anesthetics (specific IgG). One name. 20 1 860
C368 Phadiatop Infant ImmunoCAP - Children's screening panel. Determination of specific IgE for the most common allergens responsible for the development of allergies in young children (without decoding) / Recommended for children under 5 years. (Number of determinations) 27 2 512
C369 Phadiatop ImmunoCAP - Inhalation screening panel: determination of specific IgE to the main inhalation allergens (without decoding) (quantitative determination) 22 2 047
C370 Complex of studies for detection of allergens (immunocap ISAC 112 allergocomponents) 427 39 721
C381 The individual allergens, the technology ImmunoCAP, Phadia AB (one name) 12 1 116
C382 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel house dust, mixed hx2: h2 Hollister-Stier Labs, d1 dermatophagoides pteronyssinus, d2 dermatophagoides farinae, i6 crotonbug (blatella germanica) 14 1 302
C383 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel molds, mixed mx1: m1 Penicillium notatum (P. chrysogenum), m2 Cladosporium herbarum, m3 Aspergillus fumigatus, m6 Alternaria alternata 14 1 302
C384 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel molds, mixed mx2: m1 Penicillium notatum (P.chrysogenum), m2 Cladosporium herbarum, m3 Aspergillus fumigatus, m5 Candida albicans, m6 Alternaria tenuis, m8 Setomelanomma rostrata 14 1 302
C385 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel pets (epithelium), mixed ex1: e1 cat (dander), e5 dog (dander), e3 horse (dander), e4 cow (dander) 15 1 395
C386 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel pets, mixed ex2: e1 cat (dander), e5 dog (dander), e6 guinea pig (epithelium), e87 rat (epithelium, serum proteins and urine), е88 mouse (epithelium, serum proteins and urine) 19 1 767
C387 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel rodents, mixed ex70: e6 guinea pig (epithelium), e82 rabbit (epithelium), e84 hamster (epithelium), e87 rat (epithelium, serum and urine proteins), e88 mouse (epithelium, urine and serum proteins) 14 1 302
C388 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel bird feathers, mixed ex72: e78 budgerigar (feather), e201 canary (feather), e196 parakeet (feather), e213 parrot (feather), e214 wren (feather) 16 1 488
C389 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel tree pollen, mixed tx5: t2 alder, t4 hazel, t8 elm, t12 white willow, t14 poplar 16 1 488
C391 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel tree pollen, mixed tx6: t1 maple, t3 birch, t7 white oak, t5 Beech, t10 walnut 16 1 488
C392 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel tree pollen, mixed tx9: t2 alder gray (alnus incana); t3 white birch (betula verrucosa); t4 common hazell (corylus avellana); t7 white oak, t12 white willow 14 1 302
C393 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel pollen early-flowering meadow grasses, mixed gx1: g3 cocksfoot (dactylis glomerata), g4 meadow fescue (festuca elatior), g5 perennial ryegrass (chaff); g6 timothy grass (phleum pratense), g8 kentucky bluegrass 16 1 488
C394 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel the pollen of weeds, mixed wx1: w1 ragweed, w6 mugwort, w9 plantago lanceolata, w10 white goosefoot, w11 ash pan (saltwort) 16 1 488
C395 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel the pollen of weeds, mixed wx2: w2 ambrosia golometelchataya, w6 mugwort, w9 plantago lanceolata, w10 white goosefoot, w15 quinoa 16 1 488
C396 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel the pollen of weeds, mixed wx3: w6 mugwort, w9 plantago lanceolata, w10 white goosefoot, w12 goldenrod, w20 stinging nettle 19 1 767
C397 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel infant formula, mixed fx5: f1 egg white, f2 cow's milk, f3 cod, f4 wheat flour, f13 peanuts, f14 soybeans 16 1 488
C398 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel seafood, mixed fx2: f3 atlantic cod, f24 northern shrimp, f37 blue mussel, f40 tuna, f41 salmon 16 1 488
C399 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel fish mixed fx74: f3 atlantic cod, f205 herring, f206 mackerel, f254 flounder 16 1 488
C470 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel meat mixed fx74: f26 pork, f27 beef, f83 chicken 19 1 767
C471 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel flour and cereal sesame, mixed fx3: f4 wheat, f7 oat, f8 maize, f10 sesame seed, f11 buckwheat 16 1 488
C472 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel lour, cereal, mixed FX20: f4 wheat, f5 rye, f6 barley, f9 rice 16 1 488
C473 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel vegetables and legumes, mixed fx13: f12 pea, f15 white beans, f31 carrot, f35 potato 16 1 488
C474 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel vegetables, mixed fx14: f25 tomato, f214 spinach; f216 white cabbage, f218 paprika and sweet pepper 16 1 488
C475 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel nuts, mixed fx1: f13 peanut, f17 hazel nut, f18 brazil nut, f20 almond, f36 coconut 16 1 488
C476 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel citrus and fruit, mixed fx15: f33 orange, f49 apple, f92 banana, f95 peach 16 1 488
C477 Allergens sensivity determination (ImmunoCAP, Phadia AB method), panel fruits and melons, mixed fx21: f84 kiwi fruit, f87 melon, f92 banana, f95 peach, f210 peneaple 16 1 488
SPECIFIC IgG
C341 Determination of IgG class antibodies to 90 food allergens (food intolerance) 320 29 768
C463 Determination of class-specific immunoglobulin (IgG) for evaluation of nutritional maladjustment within the program "Immunohealth IT" 309 28 744
PCR
P018 DNA Salmonella, Shigella, Campylobacter, Adenovirus, DNA E.coli(EIEC), RNA Rotavirus, Astrovirus, Norovirus G2 in stool 35 3 256
P019 DNA Salmonella species in stool 25 2 326
P021 Colibacillosis 40 3 721
DIAGNOSIS OF VIRAL INFECTIONS (PCR)
P003 Human Papilloma virus 16,18,31,33,35,39,45,51,52,56,58,59 39 3 628
P009 Mycoplasma pneumoniae DNA 22 2 047
P029 RNA of influenza virus А, А/Н1N1/CA/2009, B 67 6 233
P030 HSV I & II 20 1 860
P031 Human Papilloma virus 31, 33 20 1 860
P032 Human Papilloma virus 6,11 20 1 860
P033 Herpes Simplex virus II 20 1 860
P035 H. Papilloma virus 16, 18 20 1 860
P042 Varicella-Zoster virus 20 1 860
P070 Cytomegalovirus 20 1 860
P080 Epstein-Barr virus 20 1 860
P105 Human Papilloma virus sp. 20 1 860
P004 Rubella Virus in blood (qual) 40 3 721
P120 Herpes Simplex virus VI (qual) 18 1 674
P125 Enterovirus (RNA) 33 3 070
P126 DNA Pneumocystis carinni 17 1 581
P127 ARVI diagnostic: RNA of respiratory syncytial virus, RNA of metapneumovirus, RNA of parainfluenza virus 1,2,3,4 types, RNA of rhinoviruses, DNA of adenoviruses B,C,E groups, DNA of bocaviruses 50 4 651
P128 Laboratory examination of tick to identify RNA/DNA pathogens transmitted by ticks: tick-borne encephalitis, borreliosis (Lyme disease), anaplasmosis, ehrlichiosis 73 6 791
P129 RNA Zika virus (blood) 80 7 442
P130 RNA Zika virus (ejaculate) 33 3 070
P131 RNA Zika virus (Amniotic fluid) 33 3 070
P133 Agroforestry-34 A screening study of the microflora of the urogenital tract of men (quantitative) 70 6 512
P134 Familar-24 Screening study of the microflora of the urogenital tract in women (quantitative) 32 2 977
P135 Neisseria meningitidis; Haemophilus influenzae; Streptococcus pneumonia: detection of DNA 15 1 395
P136 Determination of HCV RNA/ HBV DNA/ RNA HIV type 1 and 2 (ultra-sensitive study) 58 5 395
P140 Molecular biological study of biomaterial on SARS-CoV-19 (RNA determination, qualitative) 32 2 977
DIAGNOSIS OF BACTERIAL INFECTIONS (PCR)
P001 Chlamydia pneumoniae 20 1 860
P036 M.Tuberculosis-M.bovis 22 2 047
P038 Streptococcus group A (pyogenes) 22 2 047
P065 Listeria monocytogenes 22 2 047
P075 Pseudomonas aeruginosa 22 2 047
P085 Bordetella pertussis (PCR) 22 2 047
P095 Helicobacter pylori 38 3 535
P097 Haemophilus influenzae 20 1 860
P098 Streptococcus pneumoniae 20 1 860
P099 DNA Treponema pallidum 20 1 860
P103 Legionella pneumophila 10 930
P138 Study of feces on Yersinia pseudotuberculosis by PCR 10 930
DIAGNOSIS OF UROGENITAL INFECTIONS (PCR)
P000 Chlamydia trachomatis 20 1 860
P005 Mycoplasma hominis 20 1 860
P006 Mycoplasma genitalium 20 1 860
P015 Ureaplasma species 20 1 860
P016 Ureaplasma urealiticum (T-960) & Ureaplasma parvum (Parvo) 20 1 860
P020 Neisseria gonorrhoeae 20 1 860
P025 Gardnerella vaginalis 20 1 860
DIAGNOSIS OF PROTOZOA INFECTIONS (PCR)
P010 Trichomonas vaginalis 20 1 860
P012 Toxoplasma gondii 22 2 047
DIAGNOSIS OF FUNGAL INFECTIONS (PCR)
P037 Candida albicans (PCR) 22 2 047
DIAGNOSIS OF HEPATITIS (PCR)
P040 Hepatitis B quant. (HBV-DNA) 53 4 930
P045 Hepatitis B qualitive (HBV-DNA) 33 3 070
P050 Hepatitis C quant. (HCV-RNA) 253 23 535
P055 Hepatitis C qualitive (HCV-RNA) 38 3 535
P060 HCV-RNA (genotype determination) 40 3 721
P061 Hepatite G qual. (HGV-RNA) 40 3 721
P062 Hepatite D qual. (HDV-RNA) 40 3 721
P008 Hepatitis A Virus RNA (HAV-RNA) 40 3 721
P063 Genotype of hepatitis B 35 3 256
P101 Hepatitis C Virus RNA (ultrasensitive method) 78 7 256
P056 RNA/DNA of HIV type 1, ultrasensitive test (qualitative research) 193 17 954
P132 Definition of HIV RNA (type 1) (quantitative) 109 10 140
GENETIC ANALYSIS
G117 Cytogenetic study of the bone marrow (standard) 156 14 512
G119 Complex genetic analysis of blood on the susceptibility to alcohol and drugs: analysis of polymorphisms in genes OPRM1 (DRD2), ANKK1, ALDH2, ADH2, DAT1 157 14 605
G122 SNP identification in human IL28B gene 60 5 581
G134 Hereditary Neuropathy with Liability to Pressure Palsy. Mutations of PMP22 gene 230 21 395
G135 Hereditary Neuropathy with Liability to Pressure Palsy. Copy number variation PMP22 gene 210 19 535
G136 FISH panel Myelodysplastic syndrome (6 probes) 261 24 279
G137 CYP2D6 analysis polymorphisms 140 13 023
G138 Determination of hereditary nonpolyposis colon cancer (Lynch syndrome) 430 40 000
G139 Familial adenomatous polyposis , polypoid colon cancer 430 40 000
G154 Chromosomal Microarray Analysis (CMA) prenatal (standard) 594 55 256
G155 Chromosomal Microarray Analysis (CMA) prenatal (complicated) 820 76 279
G156 BRCA1 и BRCA2 polymorphism 225 20 930
G157 Non Invasive Prenatal Test (NIPT) Natera (USA) Basic panel. Down, Edwards, Patau syndromes 1000 93 024
G159 Sequence SCN1 A (Dravet syndrome) 825 76 745
G160 Fragile X mental retardation syndrome (methylation) 190 17 675
G162 Clinical sequencing ekzom, the family (4000 genes) 807 75 070
G163 Locus analysis of microdeletions AZF Y-chromosome (1person) 143 13 302
G165 Paternity test 480 44 651
G167 Non Invasive Fetal Rhesus factor Determination 188 17 488
G170 HLA II class typing (DRB1, DQA1, DQB1) 150 13 954
G185 PGD of family translocations (QF-PCR) preparatory stage: development of individual test systems (markers (probes), analysis informative for family) 854 79 442
G191 PGD ​​of monogenic diseases (QF-PCR) (confirmed diagnosis and genotype) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) 854 79 442
G192 PGD ​​of monogenic diseases (QF-PCR) (confirmed diagnosis genotype not known) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) договорная
G195 Non Invasive Prenatal Test (NIPT) Natera (USA) + microdeletion 1040 96 745
G196 Non Invasive Prenatal Test (NIPT) for twin pregnancy, donor programs and surrogate mothers 700 65 117
G197 Calreticulin (CALR) 115 10 698
G199 Leukodystrophy and Leukoencephalopathy next-generation sequencing panel for 59 genes 593 55 163
G216 Genetic predisposition to breast cancer and ovarian cancer 127 11 814
G218 Genetic predisposition to breast cancer in long-term hormonal contraception 239 22 233
G232 Stomach cancer 464 43 163
G233 Pancreas cancer 100 9 302
G234 Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (full-scaled) 635 59 070
G235 Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (shorten) 211 19 628
G254 Sensorineural hearing loss 43 4 000
G255 Muscle atrophy 71 6 605
G256 Long QT syndrome 99 9 209
G264 Lactose intolerance 71 6 605
G265 Gilbert's syndrome - a confirmatory test 43 4 000
G268 Psoriasis 71 6 605
G272 Determination of sensitivity to the Fluorouracil and Capecitabine (Xeloda) 43 4 000
G295 Germinal mutation of the choice of any international database (with the obligatory indication of gene polymorphism and localization) 124 11 535
G313 Organization of the study compared the allele nucleotide polymorphisms with the provision of the report in electronic form 450 41 861
G314 Organization of the study compared the allele nucleotide polymorphisms with the provision of the report in electronic form and on paper 550 51 163
G315 Full sequencing of exome 992 92 280
G316 Panel "Diseases of conjunctive tissue" 676 62 884
G317 Panel "Patrimony of cardiopathy" 676 62 884
G318 Arrhythmogenic dysplasia / cardiomyopathy of the right stomach: search for mutations in the gene SCN5A 688 64 000
G320 Syndrome of lengthened interval QT (Sequencing of genes KCNQ 1, KCNE 1,KCNQ 2, KCNH2, KCNJ2, SCN5A, SCN4B, CAV3) extended, 8 of genes 641 59 628
G322 Panel "Hypertension and selection of pharmaceutical drugs" 145 13 488
G324 Velocardiofacial syndrome: searching for deletions in region 22q11 190 17 675
G325 PGS: QF-PCR assay of 1 embryo for 24 chromosomes including X and Y 593 55 163
G326 PGS: QF-PCR assay of additional embryo for 24 chromosomes including X and Y 262 24 372
G327 PGD: QF-PCR assay of inherited translocations, 1 embryo 178 16 558
G328 PGD: QF-PCR assay of monogenic family disease, 1 embryo 178 16 558
G329 Complex test PGD+PGS (QF-PCR assay). Preliminary stage: development of an individual test system for PGD monogenic family disease 855 79 535
G330 Complex test PGD+PGS (QF-PCR assay). PGD monogenic family disease / translocation) + (PGS 24 chromosomes) 1 embryo 617 57 396
G331 Complex test PGD+PGS (QF-PCR assay). PGD monogenic family disease / translocation) + (PGS 24 chromosomes), additional embryo 252 23 442
G332 Partial analysis of the ABCD1 gene (X-linked adrenoleukodystrophy, MIM 300100) 238 22 140
G333 Myriad MyRisk 3850 358 141
G334 Myriad BRCA1 Analysis 2405 223 722
G335 Myriad BRCA2 Analysis 2495 232 094
G336 Myriad COLARIS PLUS 3290 306 048
G337 Myriad MLH1 Analysis 2055 191 164
G338 Myriad MSH2 Analysis 1786 166 140
G339 Myriad MSH6 Analysis 2185 203 257
G340 Myriad PMS2 Analysis 2051 190 792
G341 Myriad MYH Sequence Analysis 1965 182 792
G342 Myriad Comprehensive MELARIS 1667 155 071
G343 Myriad Comprehensive PANEXIA 3290 306 048
G344 The definition of ADZIC in plasma (diagnosis peroxisome diseases) 80 7 442
G355 Myriad BRAC Analysis 2850 265 118
G356 Myriad Single-Site BRACAnalysis 1184 110 140
G357 Myriad MultiSite 3 BRACAnalysis 1387 129 024
G358 Myriad Reflex BRACAnalysis 2582 240 187
G359 Myriad BRACAnalysis Rearrangement Test (BART) 1476 137 303
G360 Myriad Single-Site COLARIS 1184 110 140
G361 Myriad COLARIS AP PLUS 2850 265 118
G362 Myriad Single-Site COLARIS AP 1184 110 140
G363 Myriad MYH Mutation Panel 1100 102 326
G364 Myriad Reflex MYH Sequence Analysis 1680 156 280
G365 Myriad Single-Site MELARIS 1184 110 140
G366 Myriad Single-Site PANEXIA 1184 110 140
G367 Myriad PALB2 Analysis 2110 196 280
G375 NIPT. Natera (USA)+microdeletions (Full study. Hromosomal wide syndromes and mutations) 1092 101 582
G376 Molecular karyotyping abortion material OPTIMA 333 30 977
G377 Chromosomal micrometrical analysis of abortive material Standard 558 51 907
G378 Non-invasive prenatal DNA Harmony test (Ariosa) 642 59 721
G379 PGS 24 chromosomes by a method of NGS (for patients with normal blood karyotype) 475 44 186
G380 PGD for structural chromosome rearrangements NGS (for patients with balanced chromosomal rearrang.) 475 44 186
G388 The allocation and storage of DNA 24 2 233
G389 Panel "Disorders of hemostasis" 30 tokens 215 20 000
G394 Cytogenetics: FISH (fluorescent crossbreeding in situ) (for one token) 157 14 605
G395 Cytogenetics: FISH (fluorescent crossbreeding in situ) with whole chromosome breakdown, 1 chromosome 145 13 488
G396 Cytogenetics: MDS FISH (fluorescent crossbreeding in situ) panel with (6 probes) 262 24 372
G397 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel of MDS according to IPSS (9 probes) 380 35 349
G398 Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in AML (9 probes) 380 35 349
G399 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel when ALL the (7 probes) 298 27 721
G400 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel with multiple myeloma (10 probes) 392 36 465
G401 Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in CLL (8 probes) 333 30 977
G402 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel (hypereosinophilic syndrome, chronic eosinophilic leukemia, chronic myeloproliferative neoplasms) 2 probes 238 22 140
G425 The study of the intestinal microbiota by the method of NGS sequencing of specific 16s RNA 235 21 861
G469 Determination of polymorphisms associated with lactose metabolism 24 2 233
CHROMOSOMAL ANALYSIS
G050 Karyotype (cytogenetic analysis) 200 18 605
TISSUE TYPING
G020 HLA TYPING B27 200 18 605
MICROBIOLOGY
M000 Bacteriology & Antibiogram 80 7 442
M003 Bacterioscopic stained smear 30 2 791
M005 Microbiological study of discharge from the urethra to urealyticum ureaplasma, mycoplasma of hominis, with resistogramm 47 4 372
M006 Determination of microbiocenosis by chromatography-mass spectrometry (MSMM) 119 11 070
M010 Mycology & Fungigram 90 8 372
M100 Disbacteriosis 107 9 954
M130 Corynebacterium diphtheriae (BL) 29 2 698
M135 Enteropathogenic bacteria (BD) 35 3 256
M170 Staphylococcus aureus 52 4 837
M350 Yersinia enterocolitica (stool culture) 52 4 837
M560 Listeria (with resistance) 38 3 535
M237 The detection Candida anti-mannan antibodies in serum Platelia, Candida Ab Plus 57 5 302
M238 Determination of fungi metabolites (determination of Candida mannan antigen in blood serum, Platelia Candida Ag) 57 5 302
M239 Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (nose, pharynx, sinuses) 18 1 674
M240 Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (nose, pharynx, sinuses) 20 1 860
M241 Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (tela, stab sequestrate) 18 1 674
M242 Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (tela, stab sequestrate) 17 1 581
M243 Inoculation of N. meningitidis with the definition of sensitivity to antibiotics 15 1 395
MICOLOGY
M160 Microbiology of lavage fluid, nasopharyngeal swabs, wash water sinuses, ear discharge by fungi (microscopy and culture, 1 localization) 150 13 954
M055 Mycology of hair by dermatophytes (Dermatophyton) microscopy and culture 100 9 302
M151 Microbiology of blood by fungi (double reseeding) 130 12 093
M090 Micology Aspergillus spp. of sputum (microscopy and culture) 80 7 442
M095 Micology Cryptococcus neoformans of sputum (microscopy and culture) 130 12 093
M156 Mycology of sputum by fungi, microscopy and culture 80 7 442
M175 Microbiology of sputum by anaerobic and facultative anaerobic microbes (actinomycetes) 130 12 093
M080 Mycology Aspergillus spp. of nasopharyngeal swabs (culture) 110 10 233
M171 Microbiology of abscess by anaerobic and facultative anaerobic microbes (actinomycetes) 120 11 163
M131 Aspergillus niger. of ear discharge (micology), Aspergillus spp. culture and filamentous fungi 80 7 442
M136 Mycology of conjunctiva discharge by fungi (culture) 100 9 302
M165 Bacteriology of traumatic discharge by anaerobic and facultative anaerobic microbes (actinomycetes) 120 11 163
M060 Mycology of skin and nail samples by dermatophytes (Dermatophyton) culture, 1 localization 70 6 512
M116 Mycology Cryptococcus neoformans of cerebrospinal fluid (microscopy and culture) 80 7 442
M195 Metabolite of fungi (Cryptococcus antigen in "Cryptococcus", BIO-RAD, mannan) 90 8 372
M235 Metabolite of fungi (Aspergillus antigen in Aspergillus EIA, BIO-RAD, galactomannan) 115 10 698
M236 Aspergillus spp. Antibodies (Aspergillus fumigatus Igg) 80 7 442
COMPLEX LABORATORY TESTS
K001 Cardiorisk 440 40 930
Prothrombin+INR
Homocysteine
Cholesterol
Cholesterol-HDL
Cholesterol-LDL
Triglycerides
Sodium/Potassium/Chloride
Lactatedehydrogenase (LDH)
Creatine Kinase
Creatine Kinase MB
Alanine Amino Transferase (ALT)
Aspartate Amino Transferase (AST)
C-Reactive Protein
Myoglobin
Troponin I
BNP (brain natriuretic peptide)
K002 Lipidic screening 200 18 605
Homocysteine
Cholesterol
Cholesterol-HDL
Cholesterol-LDL
Triglycerides
Lipoprotein A
APO-A-1 protein
APO-B protein
K003 Liver Function 120 11 163
Albumin
Total protein
Bilirubin total
Bilirubin direct
Lactatedehydrogenase (LDH)
Creatine Kinase
Gamma Glutamyle Transferase (GGT)
Alk. Phosphatase
Alanine Amino Transferase (ALT)
Aspartate Amino Transferase (AST)
K004 TORCH 379 35 256
Anti-CMV IgG
Anti-CMV IgM
Anti-Rubella IgG
Anti Rubella IgM
Anti-HSV 1 IgG
Anti-HSV 1 IgM
Anti-HSV 2 IgG
Anti-HSV 2 IgM
Toxoplasma gondii IgG (quant)
Toxoplasma gondii IgM (qual)
K005 Thyroid gland 240 22 326
Thyroglobulin antibody
Thyroperoxidase antibody
Thyroid stimulating hormone
Total T3
Free T3
Total T4
Free T4
Thyroglobulin
K006 Anemia 219 20 372
Cell Blood Count+differential
Sedimentation rate
Reticulocytes
Folic acid
Vitamin B12
Iron
Iron binding capacity
Transferrin
Ferritin
K007 Osteoporosis 201 18 698
Calcium (total)
Phosphate inorganic
Alk. Phosphatase
Osteocalcin
Parathormone
Bone resorption - deoxypiridinolin
K008 Biochemical screening 160 14 884
Cell Blood Count+differential
Sedimentation rate
Creatinine
Total protein
Urea
Glucose
Cholesterol
Bilirubin total
Alk. Phosphatase
Alanine Amino Transferase (ALT)
Aspartate Amino Transferase (AST)
K010.1 Complex "Chemotherapy. Biochemical screening" №1 90 8 372
Cell Blood Count+differential
Standard urine test
Albumin
Creatinine
Total protein
Urea
Uric acid
Glucose
Bilirubin total
Calcium (total)
Sodium/Potassium/Chloride
Amylase
Gamma Glutamyle Transferase (GGT)
Alk. Phosphatase
Alanine Amino Transferase (ALT)
Aspartate Amino Transferase (AST)
K010.2 Complex "Chemotherapy. Biochemical screening" №2 85 7 907
Cell Blood Count+differential
Albumin
Creatinine
Total protein
Urea
Uric acid
Glucose
Bilirubin total
Calcium (total)
Sodium/Potassium/Chloride
Amylase
Gamma Glutamyle Transferase (GGT)
Alk. Phosphatase
Alanine Amino Transferase (ALT)
Aspartate Amino Transferase (AST)
K011 Fibro Test/ Acti Test 300 27 907
Bilirubin total
APO-A-1-protein
Gamma Glutamyle Transferase
Alanine Amino Transferase
Aspartate Amino Transferase
Alpha-2-Macroglobuline
Haptoglobin
Results processing
K012 FibroMax Test 380 35 349
Bilirubin total
APO-A-1-protein
Gamma Glutamyle Transferase
Alanine Amino Transferase
Aspartate Amino Transferase
Alpha-2-Macroglobuline
Haptoglobin
Glucose
Triglycerides
Cholesterol
Results processing
K013 LifeSpan Lab Pre-Check Male 219 20 372
Vitamin D
Magnesium
Testosterone
Dehydroepiandrosterone
Insulin
K014 LifeSpan Lab Pre-Check Female 219 20 372
Vitamin D
Magnesium
Testosterone
Estradiol
Progesterone
Insulin
CVD19 Health Certificate 170 15 814
Anti- COVID-19, IgM/IgG
Specialist's consultation on diagnostics results, anti- COVID-19, IgM/IgG (up to 2 persons)
Material sampling for diagnostic of SARS-CoV-2 (COVID-19)
CVD19.1 Health Certificate at home 150 13 954
Anti- COVID-19, IgM/IgG
Material sampling for diagnostic of SARS-CoV-2 (COVID-19)
CVD20 Health Certificate- complex COVID diagnostics (CITO) 186 17 302
Specialist's consultation on diagnostics results, anti- COVID-19, IgM/IgG (up to 2 persons)
Material sampling for diagnostic of SARS-CoV-2 (COVID-19)
Anti- COVID-19, IgM/IgG
CVD20.1 Health Certificate at home- complex COVID diagnostics (CITO) 166 15 442
Material sampling for diagnostic of SARS-CoV-2 (COVID-19)
Anti- COVID-19, IgM/IgG
PREDILECTION OF BREAST / OVARY CANCER
G009 BRCA1 5382insC 50 4 651
G010 BRCA1 4153delA 50 4 651
G011 BRCA1 185delAG 50 4 651
G012 BRCA1 C61>G 50 4 651
G014 BRCA1 2080delAA 50 4 651
G015 BRCA2 6174delT 50 4 651
G016 BRCA2 9318 delAAAA 50 4 651
G021 CHEK2 ivs2+1G>A 50 4 651
QUALITY EXPRESSION OF CHYMERA ONCOGENES BY RT-PCR
G052 BCR-ABL p210 t(9;22) 88 8 186
G053 BCR-ABL p190 t(9;22) 88 8 186
G054 BCR-ABL p230 t(9;22) 88 8 186
MUTATIONS, CHIMERISM
G097 Mutation in D816V gene c-KIT, typical of mastocytosis 105 9 767
G098 Mutation profile: V617F Jak-2, delection 12 exon Jak-2, Mpl-1 W515L/K. С 155 14 419
G099 Mutation V617F in 14 exon gene Jak-2 kinase – quantity 89 8 279
G104 Hemochromatosis, mutation in a gene HFE-C282Y and H63D (PCR- detection) 62 5 767
G106 Mutation V617F in 14exon gene Jak-2 kinase -quality 60 5 581
G107 Deletion in 12 exon gene Jak-2 kinase 86 8 000
G114 Determination of thrombophilia markers (FII, FV, MTHFR) 111 10 326
G152 Germinal mutation 62 5 767
G371 Search 12 the most frequent mutations in the gene ATP7B (Wilson Disease-Konovalova) 110 10 233
G372 Search of mutations in the gene ATP7B (Wilson Disease-Konovalova) 785 73 024
G373 Search identified in this family of mutations have a relative (Wilson Disease-Konovalova) 95 8 837
G374 Prenatal DNA diagnosis (Wilson's Disease) 193 17 954
G381 PMP22(1.5-MB Del) 29 2 698
G382 PMP22 (2-BP DEL.,207TC; rs587776691) 29 2 698
G383 PMP22 (1-BP INS, 325G; rs80338763) 29 2 698
G384 PMP22 (Ala67Thr: rs104894623) 29 2 698
G385 PMP22 (EX2-3DEL; nsv1197510) 29 2 698
G386 PDGFRα, FIP1L1 - markers of eosinophilia 88 8 186
G387 Genotyping on the RH factor, including heterozygous carrier 126 11 721
G390 Panel "Phacomatosis and hereditary cancer" 678 63 070
G407 Determination of mutations in the WT1 gene by direct sequencing (7-10 exons) 136 12 651
G408 Analysis of carriers of spinal ametropia 155 14 419
G409 Screening for hereditary diseases (2500 genes) 676 62 884
G410 Screening for hereditary diseases (5 diseases, 15 mutations) 65 6 047
G411 Search for frequent mutations in genes CFTR, PAH, SMN1, GJB2 223 20 744
G412 Search 9 most frequent mutations in the CYP210HB gene 155 14 419
G413 Analysis of spinal amyotrophy carrier for married couple (2 pers.) 183 17 023
G414 Determination carrier known inherited mutations in the family (CDH1 genes, MLH1 / MSH2, BRCA2) 83 7 721
G415 Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with the report in the electronic form 923 85 861
G416 Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with report in electronic form and on paper 1038 96 559
G417 Solo Risk:hereditary mutations associated with the risk of hereditary oncol dis. in an electr. form 1015 94 419
G418 Solo Risk:hereditary mut assoc with the risk of hereditary oncol dis in an electr form,a paper car 1130 105 117
G429 Parkinson disease - mutation screening of exons 8 to 11 of the GBA gene 119 11 070
G430 Wilson-Konovalov disease - screening of the coding region of the atp7b gene 715 66 512
G431 BAS and frontotemporal dementia - expansion in c9orf72 gene 95 8 837
G432 Neurodegenerative diseases - APOE gene genotyping 60 5 581
G433 Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoecephalopathy (CADASIL): analysis of the most frequent mutations in the NOTCH3 gene 119 11 070
G434 Frontal-temporal dementia - mutational screening of the coding region of the GRN gene 285 26 512
G435 BAS - screening of the coding region of the SOD1 gene 285 26 512
G442 The blood test for the syndrome Gerstmann-Straussler-Sheinker: search for mutations in the gene PRNP 178 16 558
G443 Complex genetic research: hereditary diseases of the gastrointestinal tract 676 62 884
G445 Full genome sequencing GenomeUNI 1840 171 164
G446 Research on the genome FERTY 1550 144 187
G447 Search for mutations in the FKTN gene (Muscular dystrophy of the Fukuyama type) 428 39 814
G448 Finding a relative’s identified mutations in this family (Muscular dystrophy of the Fukuyama type) 95 8 837
G449 Search for frequent mutations in CAPN3, FKRP, ANO5, SGCA genes (muscular dystrophy of the lumbar) 110 10 233
G451 Search for mutations in the FKRP gene (muscular dystrophy of the lumbar) 136 12 651
G452 Search for mutations in the SGCA gene (muscular dystrophy of the lumbar) 214 19 907
G453 Search for mutations in the SGCB gene (muscular dystrophy of the lumbar) 214 19 907
G454 Search revealed in this family mutations in a relative (muscular dystrophy of the lumbar) 95 8 837
G455 Prenatal DNA diagnosis (muscular dystrophy of the lumbar) 193 17 954
G456 Finding mutations in the EMD gene (Emery-Dreyfus muscular dystrophy) 136 12 651
G457 Finding mutations in the LMNA (Emery-Dreyfus muscular dystrophy) 356 33 116
G458 Finding mutations in the FHL1 gene (Emery-Dreyfus muscular dystrophy) 285 26 512
G459 Search revealed in this family mutation in a relative (Emery-Dreyfus muscular dystrophy) 67 6 233
G460 Prenatal DNA diagnosis Emery-Dreyfus muscular dystrophy 193 17 954
G461 Search for deletions and duplications in the DMD gene in boys (Duchenne/Becker muscular dystrophy) 214 19 907
G462 Search deletions and duplications in the patient's relatives in the female line (Duchenne/Becker muscular dystrophy) 250 23 256
G464 Search for a point mutation identified in this family from a relative (Duchenne/Becker muscular dystrophy) 67 6 233
G465 Prenatal DNA diagnosis (Duchenne/Becker muscular dystrophy) 193 17 954
G466 Determination of mutations in MYD88 GENE (L265P) (associated with primary resistance to ibrutinib) 137 12 744
G467 Determination of B-cell clonal rearrangement of heavy chain IG (IgH) genes 149 13 861
G468 Chromosomal micromatrix analysis advanced 712 66 233
G470 Hypertrophic cardiomyopathy (expanded panel of 118 genes) 2407 223 908
G471 Long QT syndrome (32 gene expanded panel) 2075 193 024
G472 Diseases of the conduction system of the heart (44 genes) 2075 193 024
G474 Dyslipidemia, early atherosclerosis (total panel 104 genes) 1643 152 838
G475 Molecular genetic study (search) of exon deletions and frequent inversions in the F8 gene in hemophilia A 155 14 419
G476 Molecular genetic study (search) of mutations in the F9 gene in hemophilia B 250 23 256
G477 Molecular genetic research (search) of mutations in genes F8, F9, VWF (Hemophilia) 690 64 186
G478 Analysis of 26 genes in arrhythmogenic cardiomyopathy 1650 153 489
G479 Analysis of 251 genes in ventricular arrhythmias 2380 221 396
G480 Comparison of 85 drugs, 17 genes, 935 regions (general pharmacogenetic panel) 465 43 256
G481 Analysis of 1 gene (Fabry's disease) 598 55 628
G482 Analysis of 114 genes in congenital heart diseases 1700 158 140
G483 Analysis of 18 main genes in hypertrophic cardiomyopathy (basic panel) 1577 146 698
G484 Analysis of 27 genes for diabetes MODY in young people 1245 115 815
G485 Analysis of 121 genes in dilated cardiomyopathy 1972 183 443
G486 Analysis of 10 genes in catecholaminergic polymorphic ventricular tachycardia 1564 145 489
G487 Analysis of 16 genes in pulmonary hypertension 1577 146 698
G488 Analysis of 14 genes in hypolipidemia 1245 115 815
G489 Analysis of 204 genes of cardiomyopathy (general panel) 2380 221 396
G494 Analysis of 27 genes in Brugada Syndrome 1577 146 698
G495 Analysis of 1 gene in familial amyloidosis 398 37 023
G496 Analysis of 46 genes in atrial fibrillation 1700 158 140
G497 Analysis of 23 genes in restrictive cardiomyopathy 1564 145 489
G498 Analysis of 90 genes for ventricular arrhythmias and sudden cardiac death without detected cardiac pathology 1700 158 140
G501 Gene analysis in family studies with proband (one option) 282 26 233
G506 Comparison of the PMP 22 gene in suspected Charcot-Marie-Toute disease, MLPA study method 585 54 419
G507 Data comparison in the study of changes in the 7q11.2 site (Williams syndrome), MLPA method 581 54 047
G509 Comparison of the D4Z4 repeat array of chromosome 4 in determining the permessive allele (determining the number of repeats and haplotype, MIM 158900, Landuzi Dejerine Myodystrophy) 520 48 372
URG Extra charge for urgency (with a minimum of 50) увел. тарифа на 50%/ extra charge 50%
EXPRESS DIAGNOSTICS
E002 General Biochemistry express screening 122 11 349
C-Reactive Protein
Albumin
Bilirubin total
Alanine Amino Transferase
Asparate Amino Transferase
Gamma Glutamyle Transferase
Alk. Phosphatase
Amylase
Glucose
Urea
Creatinine
Calcium
Uric acid
HISTOLOGICAL LABORATORY
SURGICAL SAMPLES
M200 Histology of surgical samples, 1 sample 213 19 814
M206 Histological examination of the placenta 300 27 907
M207 Complex histological and immunohistochemical study of endometrial cancer 400 37 209
H250 Histology of tumor surgical samples 389 36 186
H299 Intraoperative (urgent) histology and cytology 200 18 605
H270 Histology of breast wide local excision (lumpectomy) specimen 389 36 186
H271 Histology of mastectomy speciment 367 34 140
H272 Histology of sentinel lymph node with IHC if necessary 280 26 047
H273 Histology of lymph node dissection speciment 213 19 814
H277 Intraoperative control of resection margins by Mohs micrographic surgery 250 23 256
DIAGNOSTIC (BIOPSY) MATERIAL
M201 Histology simple 1-2 samples 127 11 814
M202 Hystology with supplementary staining for helicobacter pylori 227 21 116
M203 Multiple histology 3 samples and more 344 32 000
H205 Histology of scrapings of the uterus 213 19 814
H206 Histology of the mammary gland punctates 213 19 814
H207 Histology of liver bioptates 213 19 814
H208 Histology of CT-guideline needle biopsy 397 36 930
H209 Histology of skin (PUNCH-biopsy) 213 19 814
H210 Histology of skin tumors 198 18 419
H211 Histology of bone marrow patho bioptate 280 26 047
CONSULTATIONS OF SPECIMENS
H230 Consultation of histology and cytology slides 156 14 512
H231 Consultation with the making of histology specimens with paraffin blocks 224 20 837
H232 Consultation with the making of specimens and immunohistochemistry 358 33 302
H233 Consultation of histology specimens of doctor specialist - pathologist from USA (telepathology) 550 51 163
H234 Consultation histological slides by a qualified pathologist USA, University of Southern California 445 41 396
H240 Scanning histological (cytology) specimens to make digital copies (1slide) 92 8 558
H274 Consultation of histology and cytology slides by the head of pathology lab 215 20 000
H275 Consultation of histology specimens of specialist-pathologist from Europe, Helios Clinic (telepathology) 510 47 442
H278 Consultation of histological slides by a leading specialist pathologist of the Russian Federation 105 9 767
CYTOLOGY
M300 Citology / 1 lame 75 6 977
M301 Cytologic cervical smear (Pap Smear) 94 8 744
M302 Integrated cytology PAP-test and HPV typing 117 10 884
M303 Complex immunocytochemical study of thyroid neoplasms 450 41 861
M304 Complex cytological and immunocytochemical examination of pleural fluid 110 10 233
Z302 Cytology of aspirates from the uterus, the prints with an intrauterine device 78 7 256
Z303 Cytology of the mammary gland 75 6 977
Z304 Cytology of the thyroid gland punctate 117 10 884
Z305 Cytology of liquid 78 7 256
Z306 Cytology of endoscopic material 56 5 209
Z307 Cytology of scrapings from the surface of the skin and mucous 78 7 256
Z308 Cytology of surgical samples 78 7 256
Z309 Cytology of the lymph nodes punctate 94 8 744
Z311 Urine cytology for diagnosis cancer of the urinary tract 78 7 256
Z314 Identification of human papilloma DNA virus with PCR method (HPV full testing, fluid) 22 2 047
Z315 Urgent cytology performed during endoscopic procedures (preparation and evaluation of cytologic drug clinical laboratory diagnostic by cytologist) 150 13 954
IMMUNOHISTOCHEMISTRY
I001 Immunohistochemistry of breast cancer (receptors PR, ER and Her2/neu + Ki-67) 278 25 861
I002 Immunohistochemical differential diagnosis of tumors 389 36 186
I003 Immunohistochemistry of one marker panel differential diagnosis 213 19 814
I004 Immunohistochemical diagnosis of lymphoproliferative disease (lymphoma) 457 42 512
I005 Immunohistochemical (IHC) testing for Mismatch Repair Proteins in carcinomas to exclude Lynch syndrome 256 23 814
I006 Immunocytochemistry 256 23 814
I007 Immunohistochemistry with assessment of the mutational status of the ALK gene 220 20 465
I008 Complex histological and immunohistochemical analysis of biopsies of the bladder 256 23 814
I009 Immunohistochemical study of PDL-1 gene expression 275 25 582
I010 Immunohistochemical study of up to 5 antibodies 229 21 302
I011 Immunohistochemical study from 5 to 10 antibodies 361 33 582
I012 Immunohistochemical study from 10 to 20 antibodies 541 50 326
I013 Complex histological and immunohistochemical study of biopsies of the prostate 450 41 861
I014 Comprehensive histological and immunohistochemical examination of surgical tissue sample 550 51 163
GENETIC ANALYSIS
I500 Her2/neu gene mutation detection by FISH/CISH in sections from paraffin blocks 400 37 209
I501 Cytogenetic study by hybridization in situ FISH/CISH (one tube) in sections from paraffin blocks 346 32 186
I506 Identification of the codeletion 1p/19q by in situ-hybridization in a sample of tumor tissue 340 31 628
I507 Determination of the mutational status of the ROS1 gene by in situ hybridization in a tumor tissue sample 348 32 372
I508 Determination of the mutational status of the RET gene by in situ hybridization in a tumor tissue sample 348 32 372
I509 Determination of the mutational status of the MET gene by in situ hybridization in a tumor tissue sample 348 32 372
I510 Cytogenetic study (analysis of stable chromosomal aberrations) by in-situ hybridization in a tumor tissue sample 347 32 279
I511 Determination of the mutational status of the NMYC gene by in situ hybridization in a tumor tissue sample 348 32 372
I512 Determination of the mutational status of the CMYC gene by in situ hybridization in a tumor tissue sample 348 32 372
Identification of activating mutations that determine sensitivity to targeted therapy
G200 KRAS mutation exon 2 (codon12 13) (sensitivity to cetuximab) 287 26 698
G201 EGFR mutation exons 18,19,21 (sensitivity to gefitinib/erlotinib) 287 26 698
G202 EGFR gene amplification (sensitivity to cetuximab) 259 24 093
G203 BRAF mutation exon 15 (V600E) (sensitivity to vemurafenib for melanoma and sensitivity to cetuximab for colorectal cancer 178 16 558
G204 c-KIT mutation exons 9,11,13,17 (sensitivity to imatinib for GIST and melanoma) 236 21 954
G205 PDFRRa mutation exons 12,18 (sensitivity to imatinib for GIST) 112 10 419
G206 ALK gene displacement (sensitivity to crizotinib and pemetrexed) 348 32 372
G207 Determination of the methylation status of the promoter body and MGMT gene 177 16 465
G368 Tissue test in ovarian cancer treatment 3213 298 885
G369 Agression degree in prostate cancer 4310 400 932
G370 Prognostic test for evaluation of distant metastasis growth and disease progression in breast cancer (IVD) 4310 400 932
G403 Complex analysis of data on biomarkers obtained by Next Generation Seq 2436 226 606
G404 Express research of additional biomarkers 242 22 512
G405 Biological profiling of tumor (Caris Target Now) only NGS 5040 468 839
G406 Biological profiling of tumor (Caris Target Now) full profile 7750 720 934
G419 Study of genes mutations of BRCA1/BRCA2, CHEK2, ATM in tumor tissue by PCR method 1190 110 698
G426 Molecular genetic testing of mutations in IDH1 gene in a sample of tumor tissue 190 17 675
G427 Molecular genetic testing of mutations in IDH2 gene in a sample of tumor tissue 190 17 675
G436 Molecular genetic study of mutations in the PIK3CA gene in a tumor tissue sample 160 14 884
G437 Molecular genetic research in the NRAS gene in biopsy/surgical tissue sample 160 14 884
G438 Immunohistochemical study of PDL-1 gene expression 165 15 349
G439 Solo genetics standard: tumour tissue analysis (17 biomarkers) by the NGS method 899 83 628
G440 Solo Genetics Advanced: tumour tissue analysis (50 biomarkers) by NGS method 1499 139 443
G490 Molecular genetic study of tumor tissue OncoProfile 2361 219 629
G491 Molecular genetic study of tumor tissue OncoMax 4156 386 606
G492 Molecular genetic study of tumor tissue OncoImmune 1417 131 815
G493 Molecular genetic study of tumor tissue OncoLite 1417 131 815
G499 Endometrial receptivity assessment (ERA test) 1271 118 233
G502 Molecular genetic study of tumor tissue Foundation One Liquid 6100 567 445
G503 Molecular genetic study of tumor tissue Foundation One CDx 6100 567 445
G504 Molecular genetic study of tumor tissue Foundation One Heme 6100 567 445
G505 Genetic testing with assessment of mutation status of BRCA-complex and MMRd 1100 102 326
G508 Full genome profiling of a thyroid tumor 3366 313 118
G511 Comprehensive analysis of ONCONETIX biomarker data 210 19 535
Diagnosis of soft tissue sarcoma and Ewing sarcoma
I502 Translocation in Ewing sarcoma with displacement of EWS gene 346 32 186
I503 Translocation in alveolar rhabdomyosarcoma PAX3/FKHR 249 23 163
I504 Translocation in synovial sarcoma SYT/SSX 346 32 186
I505 Translocations in myxoid liposarcoma with displacement of FUS gene 346 32 186

    Mobile application EMC